Back to Authors

Jury-Garfe, Nur

0000-0002-1143-3595

Mayo Clinic

Department of Neurology, Baylor College of Medicine, Houston, TX, USA.

Citations 1

Tau-seed interactome analysis reveals distinct functional signatures in Alzheimer’s disease across model systems
Martínez, Pablo , Patel, Henika , You, Yanwen, Lopes, Daniella, Amaro, Armando , Jury, Nur , Min, Yuhao , Redding‐Ochoa, Javier , Dutta, Sayan , Ertekin‐Taner, Nilüfer , Troncoso, Juan C. , Jury-Garfe, Nur , Rochet, Jean‐Christophe , Lasagna‐Reeves, Cristian A.

No container title available | June 20, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.06.17.660179 Get It

SUMMARY Tau aggregates propagate through the brain in a prion-like manner in Alzheimer’s disease (AD) and other tauopathies, but the molecular identity and functional partners of the seeding-competent Tau species remain poorly defined. Here, we present an unbiased proteomic profiling of a high-molecular-weight (HMW) Tau-seed isolated from AD patient brains. We contrast this interactome with that of a biochemically similar, seeding-incompetent HMW-Tau species from age-matched healthy controls. Despite comprising less than 5% of total Tau in the brain, Tau-seed associates with a distinct set of proteins enriched in synaptic, mitochondrial, and vesicle-trafficking functions. Cross-species functional screening in Drosophila and mouse models identifies interactors that modulate Tau toxicity and seeding. Spatially resolved analysis of postmortem AD brains reveals heterogenous co-deposition of these proteins with Tau aggregates, suggesting functionally distinct Tau-seed complexes. Together, this dataset provides a framework for understanding selective Tau-seed toxicity and identifies candidate regulators of Tau propagation with therapeutic potential.